Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre.
作者： Hunter Robson , Rhiannon Braund , Michelle Glass , Janelle Ashton , Michael Tatley
DOI: 10.1080/15563650.2020.1828592
关键词: Injury control 、 Medicine 、 Adverse drug reaction 、 Pharmacovigilance 、 Poison control 、 Accident prevention 、 Cannabis 、 Emergency medicine 、 Adverse effect 、 Cannabinoid Receptor Agonists
摘要: Synthetic Cannabinoid Receptor Agonists (SCRA) were legally available in New Zealand (NZ) prior to May 2014. During the period November 2012–November 2019, reports of adverse events associated with...
safetylit.org
sci-hub.st 参考文章(65)
Marta Rychert, Chris Wilkins, The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution. International Journal of Drug Policy. ,vol. 26, pp. 1273- 1278 ,(2015) , 10.1016/J.DRUGPO.2015.08.006
Vicki Macfarlane, Grant Christie, Synthetic cannabinoid withdrawal: a new demand on detoxification services. Drug and Alcohol Review. ,vol. 34, pp. 147- 153 ,(2015) , 10.1111/DAR.12225
Dangers of banning spice and the synthetic cannabinoid agonists Addiction. ,vol. 105, pp. 373- 373 ,(2010) , 10.1111/J.1360-0443.2009.02845.X
Duccio Papanti, Fabrizio Schifano, Giulia Botteon, Francesca Bertossi, Jason Mannix, Daniela Vidoni, Matteo Impagnatiello, Elisabetta Pascolo-Fabrici, Tommaso Bonavigo, “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report Human Psychopharmacology-clinical and Experimental. ,vol. 28, pp. 379- 389 ,(2013) , 10.1002/HUP.2312
Chris Wilkins, A critical first assessment of the new pre‐market approval regime for new psychoactive substances (NPS) in New Zealand Addiction. ,vol. 109, pp. 1580- 1586 ,(2014) , 10.1111/ADD.12484
Monica J. Barratt, Vince Cakic, Simon Lenton, Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review. ,vol. 32, pp. 141- 146 ,(2013) , 10.1111/J.1465-3362.2012.00519.X
Maren Hermanns-Clausen, Stefan Kneisel, Bela Szabo, Volker Auwärter, Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings Addiction. ,vol. 108, pp. 534- 544 ,(2013) , 10.1111/J.1360-0443.2012.04078.X
Chris Wilkins, Janie Sheridan, Peter Adams, Bruce Russell, Sanya Ram, David Newcombe, The new psychoactive substances regime in New Zealand: a different approach to regulation: Journal of Psychopharmacology. ,vol. 27, pp. 584- 589 ,(2013) , 10.1177/0269881113491441
Amy C. Young, Evan Schwarz, Genevieve Medina, Adebisi Obafemi, Sing-Yi Feng, Colin Kane, Kurt Kleinschmidt, Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation The American Journal of Emergency Medicine. ,vol. 30, pp. 1320.e5- 1320.e7 ,(2012) , 10.1016/J.AJEM.2011.05.013
Helge Müller, Wolfgang Sperling, Martin Köhrmann, Hagen B. Huttner, Johannes Kornhuber, Juan-Manuel Maler, The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes Schizophrenia Research. ,vol. 118, pp. 309- 310 ,(2010) , 10.1016/J.SCHRES.2009.12.001